Lisata Therapeutics, Inc. (LSTA)
4.98
-0.01
(-0.20%)
USD |
NASDAQ |
Apr 14, 09:41
Lisata Therapeutics Cash from Investing (TTM) : 15.09M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Penumbra, Inc. | -404.59M |
| Protalix Biotherapeutics, Inc. | -2.366M |
| PAVmed, Inc. | -0.031M |
| Agenus, Inc. | 1.194M |
| Curis, Inc. | 2.50M |